50% Dextrose Injection Shortage
Last Updated: April 8, 2021
Status: Resolved
Reason for the Shortage
-
- Amphastar had 50% dextrose injection on allocation due to increased demand.
- Pfizer had 50% dextrose injection on shortage due to manufacturing delays.
Available Products
-
- 50% Dextrose intravenous injection, Amphastar, 50 mL Luer-Jet syringe, 10 count, NDC 76329-3301-01
- 50% Dextrose intravenous injection, Pfizer, 50 mL LifeShield syringe, 10 count, NDC 00409-4902-34
- 50% Dextrose intravenous injection, Pfizer, 50 mL Ansyr II Luer Lock syringe, 10 count, NDC 00409-7517-16
- 50% Dextrose intravenous injection, Pfizer, 50 mL vial, 25 count, NDC 00409-6648-02
Estimated Resupply Dates
-
- All marketed presentations are available.
Safety
-
- FDA has extended the expiration dating for certain lots of 50% dextrose 50 mL Abboject syringes. https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm563360.htm
Updated
Updated April 8, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 20, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.